CoChat

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

Open access

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Purpose: NRAS and BRAF mutations are common in cutaneous melanomas, although rarely detected mutually in the same tumor. Distinct clinical correlates of these mutations have not been described, despite in vitro data suggesting enhanced oncogenic effects. This study was designed to test the hypothesis that primary human cutaneous melanomas harboring mutations in NRAS or BRAF display a more aggressive clinical phenotype than tumors wild type at both loci. Experimental Design: Microdissection of 223 primary melanomas was carried out, followed by determination of the NRAS and BRAF mutational status. Genotypic findings were correlated with features known to influence tumor behavior including age, gender, Breslow depth, Clark level, mitotic rate, the presence of ulceration, and American Joint Committee on Cancer (AJCC) staging. Results: Breslow depth and Clark level varied significantly among the genotypes, with NRAS mutants showing the deepest levels and wild-type tumors the least depth. Ulceration also differed significantly among the genotypes, with BRAF mutants demonstrating the highest rate. In addition, tumors with mutated NRAS were more likely to be located on the extremities. Patients whose tumors carried either mutation presented with more advanced AJCC stages compared with patients with wild-type tumors, and specifically, were more likely to have stage III disease at diagnosis. Overall survival did not differ among the 3 groups. Conclusions: Distinct clinical phenotypes exist for melanomas bearing NRAS and BRAF mutations, whether considered together or separately, and are associated with features known to predict aggressive tumor behavior. The impact of these mutations is most evident at earlier stages of disease progression. Clin Cancer Res; 17(2); 229–35. ©2010 AACR. Clin Cancer Res; 17(2); 229–35. ©2010 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-2276

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 276

Metadata

Authors
Ellerhorst, J. A., Greene, V. R., Ekmekcioglu, S., Warneke, C. L., Johnson, M. M., Cooke, C. P., Wang, L.-E., Prieto, V. G., Gershenwald, J. E., Wei, Q., & Grimm, E. A.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Authors' Affiliations: Departments of 1Experimental Therapeutics, 2Biostatistics, 3Epidemiology, 4Pathology and Dermatology, and 5Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Corresponding author
Ellerhorst, Julie A.
Venue
Clinical Cancer Research
Published
2011-01-15
Volume
17
Issue
2
Pages
229-235
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2109545379
Cited by
243
References
17
Citations by year
2026: 6 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 10 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 12 · 2017: 18 · 2016: 14 · 2015: 26 · 2014: 34 · 2013: 35 · 2012: 15
FWCI
7.68
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA-16672, P30CA016672, P50CA093459)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Keywords
cutaneous melanoma, NRAS mutation, BRAF mutation, tumor aggressiveness, Breslow thickness, Clark level, ulceration, AJCC staging, microdissection, overall survival, clinical phenotype
MeSH terms
Humans, Melanoma, Mutation, Neoplasm Staging, Genes, ras, Skin Neoplasms, Skin Ulcer, Proto-Oncogene Proteins B-raf

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2276
The paper
Ellerhorst, J. A., Greene, V. R., Ekmekcioglu, S., Warneke, C. L., Johnson, M. M., Cooke, C. P., Wang, L.-E., Prieto, V. G., Gershenwald, J. E., Wei, Q., & Grimm, E. A. (2011). Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2276

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.